Last Updated on June 22, 2023

PharmacoVigilance Review- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Euromed Communications

Abbreviation: PharmacoVigil. Rev.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

0.00

SJR

 0.110

h-Index

 2

Rank

 25370

Important Details

Title PharmacoVigilance Review
Standard Abbreviation PharmacoVigil. Rev.
Type of Publication Journal
Discipline Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
Impact Score 0.00
SCImago Journal Rank (SJR) 0.110
h-index 2
Overall Rank 25370
Publisher Name Euromed Communications
Publication Country United Kingdom
International Standard Serial Number (ISSN) 17526752
Coverage and History 2010-2019
Best Quartile Q4
Total Citations Received
(Last 3 Year)
0

About PharmacoVigilance Review


PharmacoVigilance Review is a journal published by Euromed Communications. This journal covers the area[s] related to Health Policy, Pharmacology, Toxicology and Pharmaceutics (miscellaneous), etc. The coverage history of this journal is as follows: 2010-2019. The rank of this journal is 25370. This journal's impact score, h-index, and SJR are 0.00, 2, and 0.110, respectively. The ISSN of this journal is/are as follows: 17526752.

The best quartile of PharmacoVigilance Review is Q4. This journal has received a total of 0 citations during the last three years (Preceding 2022).


PharmacoVigilance Review Impact Score 2022-2023


The latest impact score (IS) of the PharmacoVigilance Review is 0.00. It is computed in the year 2023 as per its definition and based on Scopus data.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of PharmacoVigilance Review Impact Score 2023


Impact Score 2022 of PharmacoVigilance Review is 0.00. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of PharmacoVigilance Review. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.00
2021 0.00
2020 0.17
2019 0.00
2018 0.06
2017 0.04
2016 0.00
2015 0.07
2014 0.00

PharmacoVigilance Review h-index


  Table Setting

The h-index of PharmacoVigilance Review is 2. By definition of the h-index, this journal has at least 2 published articles with more than 2 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




PharmacoVigilance Review ISSN


The International Standard Serial Number (ISSN) of PharmacoVigilance Review is/are as follows: 17526752.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

PharmacoVigilance Review Ranking and SCImago Journal Rank (SJR)


The PharmacoVigilance Review is ranked 25370 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.110.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


PharmacoVigilance Review Publisher


Table Setting

The publisher of PharmacoVigilance Review is Euromed Communications. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2010-2019.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of PharmacoVigilance Review is PharmacoVigil. Rev.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('PharmacoVigil. Rev.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in PharmacoVigilance Review


If your area of research or discipline is related to Health Policy, Pharmacology, Toxicology and Pharmaceutics (miscellaneous), etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of PharmacoVigilance Review?

The latest impact score of PharmacoVigilance Review is 0.00. It is computed in the year 2023.


What is the h-index of PharmacoVigilance Review?

The latest h-index of PharmacoVigilance Review is 2. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of PharmacoVigilance Review?

The latest SCImago Journal Rank (SJR) of PharmacoVigilance Review is 0.110. It is calculated in the year 2023.


What is the ranking of PharmacoVigilance Review?

The latest ranking of PharmacoVigilance Review is 25370. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of PharmacoVigilance Review?

PharmacoVigilance Review is published by Euromed Communications. The publication country of this journal is United Kingdom.


What is the abbreviation of PharmacoVigilance Review?

This standard abbreviation of PharmacoVigilance Review is PharmacoVigil. Rev..


Is "PharmacoVigilance Review" a Journal, Conference or Book Series?

PharmacoVigilance Review is a journal published by Euromed Communications.


What is the scope of PharmacoVigilance Review?

The scope of PharmacoVigilance Review is as follows:

  • Health Policy
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

For detailed scope of PharmacoVigilance Review, check the official website of this journal.


What is the ISSN of PharmacoVigilance Review?

The International Standard Serial Number (ISSN) of PharmacoVigilance Review is/are as follows: 17526752.


What is the best quartile for PharmacoVigilance Review?

The best quartile for PharmacoVigilance Review is Q4.


What is the coverage history of PharmacoVigilance Review?

The coverage history of PharmacoVigilance Review is as follows 2010-2019.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Business: Theory and Practice Journal Vilnius Gediminas Technical University 13414 21 2.47
Proceedings of the ASME Turbo Expo Conference And Proceedings 17577 54 0.00
Qualitative Research Journal SAGE Publications Ltd 2108 86 3.97
Mathematical Modelling and Analysis Journal Vilnius Gediminas Technical University 11315 27 1.75
Journal, Indian Academy of Clinical Medicine Journal Indian Academy of Clinical Medicine 24608 16 0.06
Educational Measurement: Issues and Practice Journal Wiley-Blackwell Publishing Ltd 4494 59 1.53
Population Review Journal Sociological Demography Press 17841 13 0.73
Journal des Professionnels de l'Enfance Journal TPMA 27577 2 0.00
Genes and Nutrition Journal BioMed Central Ltd. 6154 61 3.28
European Journal of Wildlife Research Journal Springer Verlag 8709 56 1.99

Check complete list




PharmacoVigilance Review Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 0.00
2021 0.00
2020 0.17
2019 0.00
2018 0.06
2017 0.04
2016 0.00
2015 0.07
2014 0.00



Top Journals/Conferences in Health Policy

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Lancet Planetary Health, The
Elsevier BV | Netherlands

Health Affairs
Project Hope | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Lancet Regional Health - Americas, The
Elsevier Ltd. | United Kingdom

Implementation Science
BioMed Central Ltd. | United Kingdom

Milbank Quarterly
Wiley-Blackwell Publishing Ltd | United Kingdom

Globalization and Health
BioMed Central Ltd. | United Kingdom

BMJ Global Health
BMJ Publishing Group | United Kingdom

Lancet Regional Health - Western Pacific, The
Elsevier Ltd. | United Kingdom

European heart journal. Quality of care & clinical outcomes
Oxford University Press | United Kingdom

Journal of Health Economics
Elsevier | Netherlands

Health Services Research
Wiley-Blackwell Publishing Ltd | United Kingdom

BMJ Quality and Safety
BMJ Publishing Group | United Kingdom

Journal of the American Medical Directors Association
Elsevier Inc. | United States

See All

Top Journals/Conferences in Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Acta Pharmaceutica Sinica B
Elsevier BV | Netherlands

Theranostics
Ivyspring International Publisher | Australia

PLoS Neglected Tropical Diseases
Public Library of Science | United States

Current Protocols
John Wiley & Sons Inc. | United States

Life Sciences
Elsevier Inc. | United States

Clinical and Translational Science
Wiley-Blackwell Publishing Ltd | United Kingdom

Drug Metabolism Reviews
Informa Healthcare | United States

Nanotheranostics
Ivyspring International Publishers | Australia

Expert Review of Clinical Pharmacology
Taylor and Francis Ltd. | United Kingdom

F1000Research
| United Kingdom

Marine Drugs
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

American Journal of Pharmaceutical Education
American Association of Colleges of Pharmacy | United States

Antibiotics
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

Journal of Zhejiang University: Science B
Zhejiang University Press | China

Journal of Cardiovascular Development and Disease
MDPI AG | Switzerland

See All